Cash and cash equivalents, and restricted cash and cash equivalents per the Statements of Cash Flows consists of the following:

​

​

Interest expense paid for the three and nine months ended September 30 was $0.3 and $0.9 million in 2025 and nil and $0.1 million in 2024, respectively.

The proceeds from the exercise of warrants in September 2025 of $0.4 million was not collected from the issuing company until October 2025.  The exercise proceeds and the prepaid expenses and other current assets increase have been adjusted by that amount.  Accounts payable per the balance sheet included $1.5 million and less than $0.6 million in equipment purchases at September 30, 2025 and 2024, respectively. The asset retirement obligation included a $2.7 million change in estimated reclamation costs in the nine months ended September 30, 2025. Share capital and contributed surplus included $1.4 million and $0.2 million related to the exercise of stock options in the nine months ended September 30, 2025 and 2024, respectively.  As these did not affect cash activity at the respective dates, they were adjusted on the Consolidated Statements of Cash Flows.